Literature DB >> 31038276

Impact of haemostatic sealant versus electrocoagulation on ovarian reserve after laparoscopic ovarian cystectomy of ovarian endometriomas: a randomised controlled trial.

Jpw Chung1, Tsm Law1, Chs Chung1, Jsm Mak1, D S Sahota1, T C Li1.   

Abstract

OBJECTIVE: To evaluate the effect of haemostatic sealant compared with bipolar coagulation on ovarian reserve after laparoscopic cystectomy for ovarian endometriomas.
DESIGN: Patient-blinded, randomised controlled trial.
SETTING: University-affiliated tertiary hospital. POPULATION: Women aged 18-40 years with 3-8 cm unilateral or bilateral endometriomas.
METHODS: Ninety-four patients were randomised to receive haemostasis by the application of haemostatic sealant (n = 47) or standard care (n = 47). MAIN OUTCOME MEASURES: Primary outcome was the effect on the antral follicular count 3 months after the operation as it captures the effect on the ovary subjected to treatment. Secondary outcomes included the change in anti-Mullerian hormone, follicular-stimulating hormone and peri-operative outcomes including haemostasis, complications, pain, and satisfaction scores.
RESULTS: A total of 94 patients aged 32.36 ± 4.92 years underwent laparoscopic cystectomy for ovarian endometriomas. The average diameter of the endometrioma was 4.21 ± 1.38 cm. The increase in antral follicle count of the affected ovaries at 3 months in the intervention group (+2.36 ± 0.37) was significantly (P = 0.013) higher than that in the control group (+1.08 ± 0.36). Repeated measures analysis of variance revealed significant effect with time (P < 0.001) and of interaction of group × time (P = 0.029) for affected ovary antral follicle count. No significant difference was noted between the two groups with regard to follicular-stimulating hormone, anti-Mullerian hormone, and other secondary outcomes.
CONCLUSIONS: Applying haemostatic sealant after laparoscopic cystectomy of ovarian endometriomas produced a greater increase in antral follicle count 3 months after surgery compared with the control group. TWEETABLE ABSTRACT: RCT: Haemostatic sealant in laparoscopic cystectomy of endometriomas increase in the antral follicle count after surgery.
© 2019 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  FloSeal; haemostasis; haemostatic sealant; laparoscopic ovarian cystectomy; ovarian reserve

Mesh:

Substances:

Year:  2019        PMID: 31038276     DOI: 10.1111/1471-0528.15807

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review.

Authors:  Byung Chul Jee
Journal:  Clin Exp Reprod Med       Date:  2022-05-04

Review 2.  Impact of Surgical Management of Endometrioma on AMH Levels and Pregnancy Rates: A Review of Recent Literature.

Authors:  Ana Sofia Pais; Clara Flagothier; Linda Tebache; Teresa Almeida Santos; Michelle Nisolle
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

3.  A randomized controlled trial of ovarian reserve preservation and hemostasis during ovarian cystectomy.

Authors:  Soo Jin Park; Aeran Seol; Nara Lee; Seungmee Lee; Hee Seung Kim
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

4.  Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.

Authors:  Yaoqiu Wu; Rong Yang; Jie Lan; Haiyan Lin; Xuedan Jiao; Qingxue Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-22       Impact factor: 5.555

5.  Preservation of the ovarian reserve and hemostasis during laparoscopic ovarian cystectomy by a hemostatic agent versus suturing for patients with ovarian endometriosis: study protocol for randomized controlled, non-inferiority trial (PRAHA-2 trial).

Authors:  Hyunji Lim; Soo Jin Park; Haerin Paik; Jaehee Mun; Eun Ji Lee; Seungmee Lee; Whasun Lim; Gwonhwa Song; Seung-Hyuk Shim; Chae Hyeong Lee; Ga Won Yim; Hee Seung Kim
Journal:  Trials       Date:  2021-07-21       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.